Zhang, H., Yang, Y., Li, J., Wang, M., Saravanan, K. M., Wei, J., . . . Wei, Y. (2020). A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro. PLoS computational biology, 16(12), e1008489. https://doi.org/10.1371/journal.pcbi.1008489
Chicago Style (17th ed.) CitationZhang, Haiping, et al. "A Novel Virtual Screening Procedure Identifies Pralatrexate as Inhibitor of SARS-CoV-2 RdRp and It Reduces Viral Replication in Vitro." PLoS Computational Biology 16, no. 12 (2020): e1008489. https://doi.org/10.1371/journal.pcbi.1008489.
MLA (9th ed.) CitationZhang, Haiping, et al. "A Novel Virtual Screening Procedure Identifies Pralatrexate as Inhibitor of SARS-CoV-2 RdRp and It Reduces Viral Replication in Vitro." PLoS Computational Biology, vol. 16, no. 12, 2020, p. e1008489, https://doi.org/10.1371/journal.pcbi.1008489.